eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
- View ORCID ProfileFlorence Coussy1,2,3,
- View ORCID ProfileRania El-Botty1,
- Sophie Château-Joubert4,
- Ahmed Dahmani1,
- Elodie Montaudon1,
- View ORCID ProfileSophie Leboucher5,
- Ludivine Morisset1,
- Pierre Painsec1,
- Laura Sourd1,
- Léa Huguet1,
- Fariba Nemati1,
- Jean-Luc Servely4,6,
- View ORCID ProfileThibaut Larcher7,
- View ORCID ProfileSophie Vacher3,
- Adrien Briaux3,
- Cécile Reyes1,
- Philippe La Rosa8,9,
- Georges Lucotte8,9,
- Tatiana Popova9,10,
- View ORCID ProfilePierre Foidart11,
- Nor Eddine Sounni11,
- Agnès Noel11,
- Didier Decaudin1,2,
- View ORCID ProfileLaetitia Fuhrmann12,
- Anne Salomon12,
- Fabien Reyal13,14,
- View ORCID ProfileChristopher Mueller15,
- Petra Ter Brugge16,
- View ORCID ProfileJos Jonkers16,
- Marie-France Poupon1,
- View ORCID ProfileMarc-Henri Stern9,10,
- Ivan Bièche3,
- View ORCID ProfileYves Pommier17,* and
- View ORCID ProfileElisabetta Marangoni1,*
- 1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
- 2Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.
- 3Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.
- 4BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.
- 5Institut Curie, PSL Research University, UMR3306, 91405 Orsay, France.
- 6INRA, PHASE Department, 37380 Nouzilly, France.
- 7INRA, APEX-PAnTher, Oniris, 44300 Nantes, France.
- 8INSERM, U900, 75005 Paris, France.
- 9Institut Curie, PSL Research University, 75005 Paris, France.
- 10INSERM U830, 75005 Paris, France.
- 11Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.
- 12Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France.
- 13Surgery Department, Institut Curie, PSL Research University, 75005 Paris, France.
- 14U932, Immunity and Cancer, INSERM, Institut Curie, 75005 Paris, France.
- 15Queen's Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada.
- 16Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands.
- 17Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- ↵*Corresponding author. Email: elisabetta.marangoni{at}curie.fr (E.M.); pommier{at}nih.gov (Y.P.)
See allHide authors and affiliations
Science Translational Medicine 19 Feb 2020:
Vol. 12, Issue 531, eaax2625
DOI: 10.1126/scitranslmed.aax2625
Vol. 12, Issue 531, eaax2625
DOI: 10.1126/scitranslmed.aax2625
Florence Coussy
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
2Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.
3Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.
Rania El-Botty
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Sophie Château-Joubert
4BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.
Ahmed Dahmani
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Elodie Montaudon
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Sophie Leboucher
5Institut Curie, PSL Research University, UMR3306, 91405 Orsay, France.
Ludivine Morisset
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Pierre Painsec
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Laura Sourd
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Léa Huguet
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Fariba Nemati
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Jean-Luc Servely
4BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.
6INRA, PHASE Department, 37380 Nouzilly, France.
Thibaut Larcher
7INRA, APEX-PAnTher, Oniris, 44300 Nantes, France.
Sophie Vacher
3Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.
Adrien Briaux
3Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.
Cécile Reyes
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Philippe La Rosa
8INSERM, U900, 75005 Paris, France.
9Institut Curie, PSL Research University, 75005 Paris, France.
Georges Lucotte
8INSERM, U900, 75005 Paris, France.
9Institut Curie, PSL Research University, 75005 Paris, France.
Tatiana Popova
9Institut Curie, PSL Research University, 75005 Paris, France.
10INSERM U830, 75005 Paris, France.
Pierre Foidart
11Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.
Nor Eddine Sounni
11Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.
Agnès Noel
11Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.
Didier Decaudin
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
2Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.
Laetitia Fuhrmann
12Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France.
Anne Salomon
12Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France.
Fabien Reyal
13Surgery Department, Institut Curie, PSL Research University, 75005 Paris, France.
14U932, Immunity and Cancer, INSERM, Institut Curie, 75005 Paris, France.
Christopher Mueller
15Queen's Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada.
Petra Ter Brugge
16Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands.
Jos Jonkers
16Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands.
Marie-France Poupon
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Marc-Henri Stern
9Institut Curie, PSL Research University, 75005 Paris, France.
10INSERM U830, 75005 Paris, France.
Ivan Bièche
3Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.
Yves Pommier
17Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Elisabetta Marangoni
1Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.
Submit a Response to This Article
No eLetters have been published for this article.